GAMMA Investing’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4K Buy
292
+24
+9% +$1.65K ﹤0.01% 2806
2026
Q1
$17.1K Sell
268
-36
-12% -$2.5K ﹤0.01% 2803
2025
Q4
$24.1K Buy
304
+28
+10% +$2.37K ﹤0.01% 2504
2025
Q3
$18.2K Buy
276
+36
+15% +$2.14K ﹤0.01% 2561
2025
Q2
$12.7K Sell
240
-10
-4% -$470 ﹤0.01% 2685
2025
Q1
$12.4K Buy
250
+11
+5% +$612 ﹤0.01% 2641
2024
Q4
$15.2K Buy
239
+139
+139% +$8.04K ﹤0.01% 2406
2024
Q3
$4.91K Buy
100
+79
+376% +$3.71K ﹤0.01% 2750
2024
Q2
$946 Buy
21
+11
+110% +$374 ﹤0.01% 3073
2024
Q1
$623 Buy
+10
New +$648 ﹤0.01% 3060

Other funds holding IRON

GAMMA Investing's IRON Position: Q2 2026 in Review

GAMMA Investing increased its Disc Medicine (IRON) stake by 9% in Q2 2026, buying an estimated $1.65K and bringing the position to 292 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2806.

GAMMA Investing first reported a position in IRON in Q1 2024 and has held it in 10 quarters since. The position peaked at $24.1K in Q4 2025. 21 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • GAMMA Investing held 292 shares of Disc Medicine worth $21.4K as of Q2 2026.
  • GAMMA Investing bought 24 Disc Medicine shares in Q2 2026, an estimated $1.65K.
  • Disc Medicine made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2806 holding.
  • GAMMA Investing first reported a position in Disc Medicine in Q1 2024 and has held it in 10 quarters since.
  • GAMMA Investing's Disc Medicine position peaked at $24.1K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.